, Hong Kong

Fujikon profits almost doubled in 3Q12

Net profit margins up 8.1%.

Hong Kong electro-acoustic products designer and manufacturer Fujikon Industrial Holdings today announced its unaudited interim results for the six month ended 30 September 2012 (“1H FY2012/13”), showing a strong recovery of profitability with profit attributable to equity holders up by 7.9 times to HK$68.1 million and net margin substantially rising by 6.9 percentage points.

During 1H FY2012/13, Fujikon’s efforts to reposition the business to focus on the high-end market segment started to bear fruit. Driven by increasing orders from both new and existing clients, the Group recorded revenue of HK$845.1 million, up by 28.1% and gross profit almost doubled to HK$183.9 million over the corresponding period last year.

Gross profit margin climbed by 7.5 percentage points to 21.8%, mainly attributed to the reduction of lower margin products, as well as external factors such as a modest appreciation of the Renminbi and lower material costs. In line with the substantial growth in net profit, basic earnings per share rose 7.9 folds to HK16.59 cents.

Join Hong Kong Business community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Hong Kong Residency rule could boost office sector
The ultra-rich are also expected to set up family offices in the city.
Allegrow Biotech engineers technology to activate immune cells
The startup’s invention can be used to treat and potentially cure diseases like cancer.
Healthcare
Renminbi rise to fuel Bank of China HK’s growth
The lender expects the currency to be used more often in cross-border deals.
Retail Banking